GGrantIndex
← Search

MULTICENTER NETWORK OF NEONATAL INTENSIVE CARE UNITS

$554,330U10FY2000HDNIH

University Of Texas Hlth Sci Ctr Houston, Houston TX

Investigators

Linked publications, trials & patents

Paper 39011550Paper 38497706Paper 38416515Paper 38388715Paper 38336201Paper 37726016Paper 37640232Paper 37155165Paper 37105408Paper 36732048Paper 36480199Paper 36253076Paper 36085059Paper 35906282Paper 35864010Paper 35850744Paper 35850743Paper 35842320Paper 35835616Paper 35835615Paper 35835614Paper 35811154Paper 35786518Paper 35728925Paper 35715492Paper 35513716Paper 35320643Paper 35301420Paper 35296895Paper 35040888Paper 34862339Paper 34661629Paper 34506326Paper 34461060Paper 34251406Paper 34157349Paper 34004189Paper 33986149Paper 33953357Paper 33478957Paper 33417919Paper 33402707Paper 33082153Paper 33038899Paper 32978526Paper 32739261Paper 32474029Paper 32459430Paper 32446491Paper 32111975Paper 31880687Paper 31691959Paper 31431654Paper 31427096Paper 31337693Paper 31312035Paper 31229956Paper 30961990Paper 30737489Trial NCT01954082Trial NCT01954056Trial NCT01793129Trial NCT01793116Trial NCT01534481Trial NCT01353313Trial NCT01223287Trial NCT01223261Trial NCT01203501Trial NCT01203488Trial NCT01203475Trial NCT01203449Trial NCT01203423Trial NCT01203410Trial NCT01203358Trial NCT01203345Trial NCT01193270Trial NCT01192776Trial NCT01035697Trial NCT01030575Trial NCT01029353Trial NCT00882284Trial NCT00874393Trial NCT00874367Trial NCT00873847Trial NCT00614744Trial NCT00349726Trial NCT00233324Trial NCT00114543Trial NCT00109525Trial NCT00067613Trial NCT00063063Trial NCT00016523Trial NCT00011362Trial NCT00009646Trial NCT00009633Trial NCT00005777Trial NCT00005776Trial NCT00005775Trial NCT00005773Trial NCT00005772

Abstract

We request continued participation in the NICHD Cooperative Neonatal Research Network. Our major strengths include: l) A large patient population. In 1994 we had 16,742 births, 291 VLBW infants, and 1450 neonatal ICU admissions (97% inborn). Full and effective participation of our infants in Network trials is fostered by our faculty's conservative treatment philosophy. 2) A highly qualified PI. Dr. Tyson has extensive experience in multicenter trials, unusual expertise in experimental design, and an uncommon knowledge of "cutting edge" issues in health policy, health care economics, and outcomes research. He is not only Professor of Pediatrics and Obstetrics at UT Southwestern in Dallas but also Adjunct Professor of Epidemiology at the School of Public Health in Houston where he was Visiting Professor at the Health Policy Institute during 1993-1994. 3) A strong track record in the Network. We have ranked high in both percent of eligible infants enrolled and in total enrollment in Network studies during the past 10 years. Our PI has contributed heavily and has designed the next major trial, a trial that will last approximately 16 months and bridge the 2 funding periods. For the next funding period, he has proposed a major trial endorsed by the Steering Committee to reduce resource use, trauma, radiation, and nosocomial infection among infants equal to or less than 1000 g BW. 4) Other major strengths. These include a) a highly productive neonatal division; b) a perinatal collaborator who is quite experienced in large management trials and the PI in an application to the Perinatal Network; c) an extensive and well organized neonatal data base of proven value to the Network; and d) a follow-up clinic that has excelled in not only observational studies but also major trials of follow-up interventions, e.g. the Primary Care Trial (funded by the Agency for Health Care Policy and Research) and the Infant Health and Development Program (funded by NICHD and the Robert Wood Johnson Foundation).

View original record on NIH RePORTER →